Finasteride vs Minoxidil: Which Hair Loss Treatment Is Right for You? (2026)

Finasteride and minoxidil are the only two FDA-approved treatments for pattern hair loss. They work through completely different mechanisms, have different evidence profiles, and suit different situations. This comparison covers the clinical evidence, practical differences, side effects, cost, and who should choose which — or whether to use both.

How Do They Work Differently?

This is the core distinction, and it matters for everything else.

Finasteride blocks DHT — the cause of follicle miniaturization. Male pattern hair loss is caused by dihydrotestosterone (DHT), an androgen derived from testosterone. In men with the genetic predisposition, DHT binds to follicle receptors and causes progressive miniaturization — thinner, shorter hairs over years, eventually no hair at all. Finasteride inhibits the enzyme (5-alpha reductase type II) that converts testosterone to DHT, reducing scalp DHT by approximately 70% and serum DHT by 60-70%.

Minoxidil stimulates hair growth — but doesn't address the cause. Minoxidil is a potassium channel opener and vasodilator. Applied topically (or taken orally), it prolongs the anagen (growth) phase of the hair cycle, increases blood flow to follicles, and causes miniaturized follicles to partially enlarge. It does not block DHT. This means hair loss progression continues while minoxidil is active — minoxidil compensates for ongoing miniaturization rather than stopping it.

The analogy: finasteride is like fixing the leak; minoxidil is like bailing out the boat.

Head-to-Head: The Clinical Evidence

| | Finasteride 1mg | Minoxidil 5% Topical | |---|---|---| | Mechanism | DHT blocker (5-AR type II) | Growth stimulator / vasodilator | | FDA approval | Yes (men only) | Yes (men and women) | | Efficacy at 12 months | ~80% improve or maintain | ~52-59% improve or maintain | | Regrowth vs. placebo | +65% visible regrowth | +45% visible regrowth | | Best for | Crown, mid-scalp, hairline | Crown, mid-scalp | | Requires prescription | Yes | No (OTC) | | Available for women | No (not approved) | Yes (2% FDA-approved) | | Cost | $22-40/mo via telehealth | $15-30/mo | | Main side effect | Sexual (2-4%) | Scalp irritation, initial shedding |

The 80% vs. 52% figures come from the landmark 2021 JAMA Dermatology combination study, which is the most relevant head-to-head reference in the current literature. Individual study results vary, but this advantage for finasteride has been consistent across the evidence base.

Effectiveness: How Much of a Difference Does It Make?

The evidence is clear that finasteride outperforms minoxidil as a single agent for male pattern hair loss. Finasteride works by addressing the cause; minoxidil manages a symptom. Over time, this difference compounds:

• At 5 years, finasteride maintains or improves hair in approximately 90% of continued users
• Long-term minoxidil data shows good results with consistent use, but users who develop even minor compliance gaps lose ground more quickly because the underlying cause (DHT) is still active

The practical difference varies by individual. Some men respond exceptionally well to minoxidil alone. A minority respond poorly to finasteride. Both drugs have non-responders.

Combination therapy is where the evidence gets unambiguous. The 2021 JAMA Dermatology study found:

• Combination (finasteride + minoxidil): 94.1% showed improvement at 12 months
• Finasteride alone: 80.5%
• Minoxidil alone: 59.0%
• Placebo: 11.8%

If you can tolerate both and can afford both, the combination is the evidence-based gold standard.

Side Effects: Very Different Profiles

The side effect profiles of these two drugs differ substantially.

Finasteride Side Effects

• Sexual side effects (decreased libido, erectile dysfunction, decreased ejaculate volume) in approximately 2-4% of men in clinical trials, compared to ~2% in placebo group
• Almost always reversible upon stopping
• Post-finasteride syndrome (persistent symptoms after stopping) is a rare but real phenomenon acknowledged in FDA labeling; prevalence is contested but appears to be well under 1%
• Not for women who are or may become pregnant — causes birth defects in male fetuses

Minoxidil Side Effects

• Scalp irritation, itching, redness — common, particularly with the propylene glycol-containing liquid solution; foam formulation substantially reduces this
• Initial shedding in the first 2-6 weeks — temporary follicle resynchronization, not treatment failure; stopping because of this is one of the most common mistakes
• Unwanted facial/body hair — possible with systemic absorption, more common with oral minoxidil
• Cardiovascular effects — minimal with topical at standard doses; relevant with oral minoxidil (requires prescription and monitoring)

For most men, minoxidil's side effects are less concerning than finasteride's. But finasteride's side effects, while less common, are more significant when they occur.

Cost Comparison

| | Finasteride | Minoxidil (topical) | |---|---|---| | Generic via telehealth | $22-35/month | — | | OTC (Kirkland 5% Foam) | — | $15/month | | Brand (Rogaine 5%) | — | $30-38/month | | Both combined (telehealth) | $35-50/month for the combination | — |

Minoxidil wins on pure cost for topical use — especially generic Kirkland, which is identical to Rogaine at half the price. Finasteride requires a prescription, which means a telehealth subscription or doctor's visit. The combination approach through a telehealth platform typically runs $35-50/month total.

Who Should Choose Which?

Choose finasteride if:

• You are a man with early to moderate androgenetic alopecia
• You want the most effective single treatment
• Your hair loss pattern includes hairline recession (finasteride is more effective here)
• You are willing to take a daily prescription medication indefinitely
• You understand and accept the side effect profile

Choose minoxidil if:

• You are a woman with female pattern hair loss (finasteride is not approved for women)
• You want an OTC option without a prescription
• You have contraindications to finasteride
• You prefer topical treatment with a lower systemic side effect profile
• You have already tried finasteride and want to add a complementary treatment

Use both if:

• You want the maximum evidence-based result (94% improvement in combination studies)
• You are a man willing to manage two treatments
• Your hair loss is moderate to significant and you want the strongest available approach

The combination is available through all major telehealth platforms (Hims, Keeps, Ro) and is often priced competitively as a bundle.

The Bottom Line

Finasteride is more effective as a single agent for male pattern hair loss — it addresses the cause rather than the symptom. Minoxidil is appropriate for women, for men who cannot or will not take finasteride, and as a powerful adjunct for anyone who wants to maximize their results.

The most effective approach for men with progressive androgenetic alopecia is the combination. Start with finasteride for root-cause treatment, add minoxidil for additional growth stimulation, and give the protocol 12 full months before drawing conclusions.

For men considering starting treatment, both are available through telehealth platforms with physician oversight. Read our complete finasteride guide for the detailed breakdown on finasteride alone, and our best minoxidil rankings for product comparisons.

Sources

1. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002;47(3):377-385. PMID: 12196747.
2. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Journal of the American Academy of Dermatology. 1998;39(4):578-589. PMID: 9777765.
3. Hu R, Xu F, Han Y, et al. Comparison of finasteride and minoxidil alone and in combination in treating male androgenetic alopecia: evidence from a meta-analysis. JAMA Dermatology. 2021;157(11):1365-1367. PMID: 34613349.
4. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2017;77(1):136-141. PMID: 28366521.
5. U.S. Food and Drug Administration. Propecia (finasteride 1mg) NDA approval, 1997; Minoxidil topical OTC approval, 1988. FDA Drug Approvals and Databases.

---

We earn $40-80/signup from Keeps and $50-100/signup from Hims. Our methodology page explains our full affiliate disclosure. These commissions do not influence our clinical assessments.